Esketamine Bests Quetiapine for Resistant Depression ...Middle East

News by : (Medscape) -
Intranasal esketamine (Spravato, Janssen) is superior to extended-release quetiapine (Seroquel, AstraZeneca) for treatment-resistant depression, results of a multicenter, head-to-head phase 3 trial show. Medscape Medical News

Hence then, the article about esketamine bests quetiapine for resistant depression was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Esketamine Bests Quetiapine for Resistant Depression )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار